MTOR and neoplasm: Although tumor angiogenesis activity is initially decreased with VEGFR inhibition, the development of resistance may be mediated by an upregulation of the phosphoinositide-3 kinase (PI3K)/Akt/mammalian target of rapamycin (mTOR) pathway [10–12].